Posts

New cancer treatment offers hope to patients out of options - Al Mayadeen English

Image
Oncologists in the UK discover that combining immunotherapy with guadecitabine, a novel investigational medicine, can reverse cancer's resistance to immunotherapy. New cancer treatment offers hope to patients out of options. A newly discovered cancer treatment can stop the disease from advancing in patients who are resistant to immunotherapy.  Immunotherapy is a type of cancer treatment that employs the immune system to target and kill cancer cells. It can save lives when other treatment choices, such as surgery, radiotherapy, or chemotherapy, have failed. Treatment cannot, however, benefit all patients, and some tumors can adapt to resist it. Oncologists in the United Kingdom have discovered that combining immunotherapy with guadecitabine, a novel investigational medicine, can reverse cancer's resistance to immunotherapy. They discovered that patients who were anticipated to die after exhausted all therapy options lived far longer. Read next: Almos...

Sub-lobar surgery for peripheral non-small cell lung cancer non-inferior to lobectomy - Medical Xpress

Image
Cancer cell during cell division. Credit: National Institutes of Health A large international study of patients with non-small cell lung cancer tumors that are two centimeters or less found that sub lobar surgery was non-inferior to lobectomy, according to results presented today at the IASLC World Conference on Lung Cancer 2022 in Vienna. In sub-lobar resection, the surgeon removes only the tumor and a small portion of the lung compared to a lobectomy where an entire portion of the lung is removed. The increased detection of small-sized peripheral non-small cell lung cancer has renewed interest in sub-lobar resection in-lieu of lobectomy, according to N.K. Altorki, MD, from Weill Cornell Medicine-New York Presbyterian Hospital in New York City. Dr. Altorki and his ...

Sequential afatinib/osimertinib in NSCLC | OTT - Dove Medical Press

Image
Introduction Three generations of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) are available for the first-line treatment of patients with EGFR mutation-positive non-small cell lung cancer (NSCLC): the first-generation reversible EGFR TKIs (erlotinib and gefitinib), the second-generation ErbB family blockers (afatinib and dacomitinib) and the third-generation irreversible EGFR TKI, osimertinib. 1 The head-to-head randomized trials, LUX-Lung 7, 2 ARCHER-1050, 3 and FLAURA 4 have shown that afatinib, dacomitinib and osimertinib confer significant clinical benefit versus first-generation EGFR TKIs. However, second- and third-generation EGFR TKIs have never been directly compared in prospective trials. Accordingly, optimal treatment in individual patients is still open to debate. This is particularly the case in Asian patients, as no second- or third-generation agent has shown a survival advantage over first-generation agents in this setting, probably re...

Case 26-2022: A 48-Year-Old Woman with Cystic Lung Disease | NEJM - nejm.org

Image
Editors Richard C. Cabot, Founder, Eric S. Rosenberg, M.D., Editor, David M. Dudzinski, M.D., Associate Editor, Meridale V. Baggett, M.D., Associate Editor, Kathy M. Tran, M.D., Associate Editor, Dennis C. Sgroi, M.D., Associate Editor, Jo-Anne O. Shepard, M.D., Associate Editor, Emily K. McDonald, Production Editor, Tara Corpuz, Production Editor

Lung cancer symptoms: 8 warning signs to know as NHS urges people to go for earlier checks - NationalWorld

Image
The NHS is urging people with suspected lung cancer symptoms to go for earlier GP checks to try and catch the disease sooner. Lung cancer is the biggest cause of cancer-related deaths in England, with 26,410 patients dying last year making it the fifth biggest cause of death overall in England. The Help Us Help You campaign, launched on World Lung Cancer Day, targets those most at risk, including over-60s and people from working-class backgrounds who are often more reluctant to visit their GP. The disease does not usually cause noticeable symptoms until it is spread through the lungs or into other parts of the body, meaning the outlook for the condition is not as good as many other types of cancer. Around one in three people with the condition live for at least one year after they are diagnosed, and about one  in 20 people live at least 10 years. Cally Palmer, NHS England national cancer director said it was "imperative" that people are aware of the symptoms and come...

Prostate cancer: Surgical robot cuts hospital stays - BBC

Image
Cambridge University Hospitals NHS Trust Prostate cancer patients are able to return home days sooner than previously thanks to the use of a robot in surgery, a hospital says. Surgeons at Addenbrooke's Hospital in Cambridge use the robot to remove cancerous tissues. The surgery makes small incisions in the patient's abdomen, resulting in less blood loss and pain. Where open surgery often meant a four or five day stay, robotic prostatectomy patients can go home 24 hours later. Cambridge University Hospitals Trust said bed space is freed up by using a surgical robot. Nursing staff care for the patient after surgery before discharging them the following morning. Cambridge University Hospitals NHS Trust Alistair Forsyth, 64, was recently diagnosed with prostate cancer and decided to have the robotic prostatectomy procedure. "Knowing I would be home the next day made a real difference to me when I was weighing up my treatment options," he said. "I want to be free of c...

Q&A: Lung cancer and treatment options by Dr. Vaida - Concord Monitor

Image
Arts-Life > Health "> Dr. Alexandru Vaida Published: 8/6/2022 2:51:22 PM Modified: 8/6/2022 2:48:04 PM Dr. Alexandru Vaida of Concord Hospital Cardiothoracic Surgery discusses lung cancer causes and the various treatment options available. What causes lung cancer? The primary cause of lung cancer is smoking, both in smokers themselves and individuals consistently exposed to it secondhand. The second most common cause of lung cancer, and the primary cause of it in non-smokers, is exposure to radon gas. Other causes include exposure to certain chemicals and particle air pollution. The WHO classifies lung cancer as a global epidemic. There are roughly 160,000...